FBXO family genes promotes hepatocellular carcinoma via ubiquitination of p53
Open Access
- 14 October 2024
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 150 (10) , 1-18
Abstract
FBXO protein family plays an essential role in the ubiquitination process acting as E3 ligases, which may contribute to the progression of cancers. However, the molecular functions of FBXOs in hepatocellular carcinoma (HCC) remain incompletely understood. Here, we investigated the overlapping genes between the FBXOs and differentially expressed genes (DEGs) of HCC identified by utilizing The Cancer Genome Atlas (TCGA) dataset, then, a prognostic model with effective predictive capacity was constructed based on the uni-cox and LASSO regression analyses. To elucidate the underlying mechanism of the FBXO model genes, KEGG analysis was carried out. Drug metabolism-cytochrome P450 and retinol metabolism were revealed as the potential pathway, which Increased the credibility of subsequent drug prediction research. Meanwhile, patients divided by the prognostic model showed a different immune infiltrating status and we also found FBXO model genes may ubiquitinate P53, inducing TP53 more prone to mutations, thereby promoting the occurrence and development of tumors. Consistent with these findings, the result of immunohistochemistry (IHC) validated an elevated expression of these model genes in HCC tissues than in the adjacent tissues. The primary aim of this investigation is to formulate a prognostic model while exploring the underlying mechanisms associated with FBXO genes in HCC. These findings offer initial research perspectives on the involvement of FBXO genes in HCC and contribute to the discovery of dependable biomarkers for the management, prognostication, and early detection of HCC in patients.Keywords
Funding Information
- National Natural Science Foundation of China (No. 82203310)
This publication has 53 references indexed in Scilit:
- Ubiquitin-specific peptidase 1: assessing its role in cancer therapyClinical and Experimental Medicine, 2023
- SCF‐FBXL8 contributes to liver metastasis and stem‐cell‐like features in colorectal cancer cells by mediating ubiquitination and degradation of TP53Clinical and Translational Medicine, 2023
- Association between F‐box‐only protein 43 overexpression and hepatocellular carcinoma pathogenesis and prognosisCancer Medicine, 2023
- FBXO6 regulates the antiviral immune responses via mediating alveolar macrophages survivalJournal of Medical Virology, 2022
- Tumor‐associated macrophages in liver cancer: From mechanisms to therapyCancer Communications, 2022
- Hepatobiliary Tumor Organoids Reveal HLA Class I Neoantigen Landscape and Antitumoral Activity of Neoantigen Peptide Enhanced with Immune Checkpoint InhibitorsAdvanced Science, 2022
- Long noncoding RNA DARS‐AS1 regulates TP53 ubiquitination and affects ovarian cancer progression by modulation miR‐194‐5p/RBX1 axisJournal of Biochemical and Molecular Toxicology, 2021
- Analysis of single‐cell RNAseq identifies transitional states of T cells associated with hepatocellular carcinomaClinical and Translational Medicine, 2020
- Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3Cell, 2019
- Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironmentCancer Cell, 2006